U-M researchers develop a personalized RNA therapeutic used to treat twins with an ultra-rare form of Batten disease
September 25, 2024 ANN ARBOR, Mich. — In a remarkable display of bench to bedside science, a therapeutic developed by U-M’s Michelle Hastings, Ph.D., is now being used to treat twin girls with a rare form of juvenile Batten disease. Hastings, who is the Pfizer Upjohn Research Professor of Pharmacology, Director of RNA Therapeutics at…